======= CLK2 =======
== Gene Information ==
* **Official Symbol**: CLK2
* **Official Name**: CDC like kinase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1196|1196]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P49760|P49760]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CLK2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CLK2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602989|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. {ECO:0000269|PubMed:10480872, ECO:0000269|PubMed:19168442, ECO:0000269|PubMed:8910305, ECO:0000269|PubMed:9637771}.
|Pkinase Tyr|
|Pkinase|
|negative regulation of gluconeogenesis|
|protein serine/threonine/tyrosine kinase activity|
|negative regulation of cellular carbohydrate metabolic process|
|regulation of gluconeogenesis|
|negative regulation of carbohydrate metabolic process|
|protein tyrosine kinase activity|
|negative regulation of small molecule metabolic process|
|regulation of carbohydrate biosynthetic process|
|response to retinoic acid|
|regulation of glucose metabolic process|
|regulation of RNA splicing|
|regulation of cellular carbohydrate metabolic process|
|peptidyl-tyrosine phosphorylation|
|peptidyl-tyrosine modification|
|response to ionizing radiation|
|protein autophosphorylation|
|regulation of carbohydrate metabolic process|
|nuclear body|
|response to acid chemical|
|protein serine/threonine kinase activity|
|nuclear speck|
|regulation of small molecule metabolic process|
|response to radiation|
|response to lipid|
|peptidyl-amino acid modification|
|protein phosphorylation|
|identical protein binding|
|response to abiotic stimulus|
|phosphorylation|
|ATP binding|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|response to oxygen-containing compound|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-1.76|
|[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|2.42|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 2/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|1/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3425
* **Expression level (log2 read counts)**: 6.67
{{:chemogenomics:nalm6 dist.png?nolink |}}